NDC product
up and up cough plus chest congestion
NDC 11673-627 · Target Corporation
Key facts
| Product NDC | 11673-627 |
|---|---|
| Proprietary name | up and up cough plus chest congestion |
| Nonproprietary name | Dextromethorphan HBr, Guaifenesin |
| Substances | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN |
| Dosage form | SOLUTION |
| Route | ORAL |
| Labeler | Target Corporation |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M012 |
| Pharmacologic classes | Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC] and 1 more |
| Marketing start | Aug 23, 2018 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: